coin-img-ETHETH+0.22%coin-img-BTCBTC+0.49%coin-img-SOLSOL+0.21%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.36%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+2.89%coin-img-GRAMTONGRAMTON-2.07%coin-img-ETHETH+0.22%coin-img-BTCBTC+0.49%coin-img-SOLSOL+0.21%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.36%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+2.89%coin-img-GRAMTONGRAMTON-2.07%coin-img-ETHETH+0.22%coin-img-BTCBTC+0.49%coin-img-SOLSOL+0.21%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.36%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+2.89%coin-img-GRAMTONGRAMTON-2.07%coin-img-ETHETH+0.22%coin-img-BTCBTC+0.49%coin-img-SOLSOL+0.21%coin-img-USDCUSDC-0.02%coin-img-XRPXRP-0.36%coin-img-TRXTRX+0.57%coin-img-HYPEHYPE+2.89%coin-img-GRAMTONGRAMTON-2.07%
user-avatar
Euronext Markets: Real-time Stock Market Data | live

Smith+Nephew cuts 2026 revenue growth outlook to around 4% as U.S. knee implant demand weakens

AI Market Summary
Smith+Nephew cut its 2026 revenue growth outlook to ~4% after a weak Q2, driven by a sharp decline in U.S. knee implant sales and softer orthopaedics performance, alongside ongoing pressure from skin substitute reimbursement. The stock sold off sharply on the update, highlighting execution and demand risks in its largest market. Broader market impact is limited, but it may weigh on medtech sentiment.
Impact level
● Low
Affected assets
NCCOGOLD2USD/USDT+1.26%
AI Insight · NCCOGOLD2USD/USDTAI Insight
▼ Bearish
Trade now
⚠️ AI-generated insights are based on news content and are provided for informational purposes only. They do not constitute investment advice or represent the views of BingX. Investing involves risk. Please trade responsibly.
Smith+Nephew lowered its 2026 full-year revenue growth forecast to around 4% from about 6%, citing notably weak demand for knee implants in the U.S. Second-quarter revenue rose 1.6%, missing analysts’ expectations of 3.7%, according to Reuters. Orthopaedics revenue fell 1%, with U.S. knee implants down 7.2% and U.S. hip implants down 1.5%. The shares slid as much as 7.9% intraday.
Disclaimer: The content above is only the author's opinion and does not represent BingX’s stance. It shall not be construed as investment advice from BingX. For details, refer to the Terms and Conditions.
Stocks

Risk Warning

Cryptocurrencies and their derivatives are innovative financial products with great volatility and high investment risks.

Although BingX is committed to providing users with easy-to-use trading tools, trading itself is still a highly sophisticated field. Trading digital assets and their derivatives are subject to high market risk and price volatility and may result in partial or total loss of account funds. You must carefully consider and exercise clear judgment to evaluate your financial situation and the aforementioned risks before using BingX Services. You shall be responsible for all losses arising therefrom. If necessary, please consult relevant professionals to make informed decisions before investing. By accessing, downloading, using or clicking on "I agree" to accept any BingX Services provided by BingX, you agree that you have read, understood and accepted all of the terms and conditions stipulated in BingX Terms of Use as well as our Privacy Policy.


Trading by copying or replicating the trades of other traders involves a high level of risks, even when copying or replicating the top-performing traders. Past performance of a BingX community member is not a reliable indicator of his future performance. Content on BingX's trading platform is generated by members of its community and does not contain advice or recommendations by or on behalf of BingX.